
    
      Open, non-comparative, interventional, multicenter study with the total number of screened
      subjects of 66 (60 evaluable subjects +6 potential screening failure):

        -  20 patients will be administered Plenhyage® thin for the treatment of mild wrinkles;

        -  20 patients will be administered Plenhyage® medium for the treatment of moderate
           wrinkles;

        -  20 patients will be administered Plenhyage® strong for improving the skin tones and
           irregularities (atrophies) of the skin surface in neck, abdomen, thighs and buttocks;
    
  